Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Udi: (b)(4).Investigation summary: the device was received and evaluated at the service center.The complaint was not confirmed.The following information was derived from the service report: per service manual operational and diagnostic analysis does not confirm the reported issue (pinch valve on the suction side of the device did not have a sufficient seal on the tubing).Per sb, performed software upgrade to 3.11.Also replaced damage console cover.The testing of the unit was completed per the service manual.The unit passed all functional tests and is fully operational.Since the issue reported by the customer was not reproduced, no root cause is avialable for the reported failure.The console cover was most likely caused by user mishandling.At this point, no corrective action is required and no further action is warranted.However, depuy synthes mitek will continue to track any related complaints within this device family as a means of monitoring the extent with which this complaint is observed in the field.This report is being filed as required under mitek's corrective and preventative actions (capa) to file usa fda mdr missed malfunctions.
|
It was reported by the sales rep via phone that during a shoulder repair procedure the customer's fms vue fluid management system pinch valve on the suction side of the device did not have a sufficient seal on the tubing.The sales rep stated the case was completed by holding this device to create better suction with no patient harm or delays.The sales rep was not present for the case and could not provide any additional information.There was no delay in the surgical procedure.There was a spare device available for use to complete the surgery.There was patient involvement.There were no reports of injuries, medical intervention or prolonged hospitalization.All available information has been disclosed.If additional information should become available, a supplemental medwatch will be submitted accordingly.
|